Clinuvel Pharmaceuticals (UR9A.F) Q1 2024 Earnings

Feb 22Confirmed
Q3 2022
Q1 2023
Q3 2023
Q1 2024
0.13
0.16
0.19
0.22

Details

Expected EPS
N/A
Actual EPS
0.127228951899
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Clinuvel Pharmaceuticals⁩ (⁦UR9A.F⁩) has reported earnings of ⁦0.127228951899⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts